APOL1 Gene Focal segmental glomerulosclerosis type 4 susceptibility to Genetic Test
Test Name: APOL1 Gene Focal segmental glomerulosclerosis type 4 susceptibility to Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Hepatology Nephrology Endocrinology Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test gene APOL1
Test Details: The APOL1 gene is associated with a condition called focal segmental glomerulosclerosis (FSGS) type 4. FSGS is a kidney disorder characterized by scarring of the glomeruli, which are the tiny blood vessels in the kidneys that filter waste from the blood. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the APOL1 gene. This test can identify specific variations or mutations in the gene that are associated with an increased risk of developing FSGS type 4. By detecting these genetic variations, NGS testing can help determine an individual’s susceptibility to FSGS type 4. This information can be useful in diagnosing the condition, predicting its progression, and guiding treatment decisions.
Test Name | APOL1 Gene Focal segmental glomerulosclerosis type 4 susceptibility to Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with APOL1 Gene Focal segmental glomerulosclerosis type 4, susceptibility to NGS Genetic DNA Test gene APOL1 |
Test Details |
The APOL1 gene is associated with a condition called focal segmental glomerulosclerosis (FSGS) type 4. FSGS is a kidney disorder characterized by scarring of the glomeruli, which are the tiny blood vessels in the kidneys that filter waste from the blood. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze the DNA sequence of the APOL1 gene. This test can identify specific variations or mutations in the gene that are associated with an increased risk of developing FSGS type 4. By detecting these genetic variations, NGS testing can help determine an individual’s susceptibility to FSGS type 4. This information can be useful in diagnosing the condition, predicting its progression, and guiding treatment decisions. |